330 related articles for article (PubMed ID: 25536529)
1. Community practice patterns for bacterial corneal ulcer evaluation and treatment.
Park J; Lee KM; Zhou H; Rabin M; Jwo K; Burton WB; Gritz DC
Eye Contact Lens; 2015 Jan; 41(1):12-8. PubMed ID: 25536529
[TBL] [Abstract][Full Text] [Related]
2. Community opinions in the management of corneal ulcers and ophthalmic antibiotics: a survey of 4 states.
Hsu HY; Nacke R; Song JC; Yoo SH; Alfonso EC; Israel HA
Eye Contact Lens; 2010 Jul; 36(4):195-200. PubMed ID: 20626115
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
[TBL] [Abstract][Full Text] [Related]
5. Differential care of corneal ulcers in the community based on apparent severity.
McLeod SD; DeBacker CM; Viana MA
Ophthalmology; 1996 Mar; 103(3):479-84. PubMed ID: 8600426
[TBL] [Abstract][Full Text] [Related]
6. Current diagnosis and treatment of corneal ulcers.
Benson WH; Lanier JD
Curr Opin Ophthalmol; 1998 Aug; 9(4):45-9. PubMed ID: 10387468
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
[TBL] [Abstract][Full Text] [Related]
9. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
Panda A; Ahuja R; Sastry SS
Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
[TBL] [Abstract][Full Text] [Related]
10. Community care of corneal ulcers.
McDonnell PJ; Nobe J; Gauderman WJ; Lee P; Aiello A; Trousdale M
Am J Ophthalmol; 1992 Nov; 114(5):531-8. PubMed ID: 1443013
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes.
Durrani AF; Atta S; Bhat AK; Mammen A; Dhaliwal D; Kowalski RP; Jhanji V
Am J Ophthalmol; 2020 Jun; 214():119-126. PubMed ID: 32209347
[TBL] [Abstract][Full Text] [Related]
13. Microbial keratitis in Thailand: a survey of common practice patterns.
Tananuvat N; Suwanniponth M
J Med Assoc Thai; 2008 Mar; 91(3):316-22. PubMed ID: 18575283
[TBL] [Abstract][Full Text] [Related]
14. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis.
McLeod SD; Kolahdouz-Isfahani A; Rostamian K; Flowers CW; Lee PP; McDonnell PJ
Ophthalmology; 1996 Jan; 103(1):23-8. PubMed ID: 8628555
[TBL] [Abstract][Full Text] [Related]
15. Comparison of topical fixed-combination fortified vancomycin-amikacin (VA solution) to conventional separate therapy in the treatment of bacterial corneal ulcer.
Chiang CC; Lin JM; Chen WL; Chiu YT; Tsai YY
Eye (Lond); 2009 Feb; 23(2):294-8. PubMed ID: 18188174
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis, laboratory analysis, and treatment of bacterial corneal ulcers.
Stonecipher KG; Jensen H
Optom Clin; 1995; 4(3):53-64. PubMed ID: 7767019
[TBL] [Abstract][Full Text] [Related]
17. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
Sharma N; Arora T; Jain V; Agarwal T; Jain R; Jain V; Yadav CP; Titiyal J; Satpathy G
Cornea; 2016 Jan; 35(1):56-61. PubMed ID: 26509763
[TBL] [Abstract][Full Text] [Related]
18. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124
[TBL] [Abstract][Full Text] [Related]
19. Empirical or culture-guided therapy for microbial keratitis? A plea for data.
McDonnell PJ
Arch Ophthalmol; 1996 Jan; 114(1):84-7. PubMed ID: 8540856
[TBL] [Abstract][Full Text] [Related]
20. The utility of culturing corneal ulcers in a tertiary referral center versus a general ophthalmology clinic.
Rodman RC; Spisak S; Sugar A; Meyer RF; Soong HK; Musch DC
Ophthalmology; 1997 Nov; 104(11):1897-901. PubMed ID: 9373123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
